Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share
Tweet Send to a FriendGet Alerts HEB Hot Sheet
Price: $0.21 --0%
Financial Fact:
Interest and other income: 181K
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Interest and other income: 181K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade HEB Now!
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Jefferies Upgrades WellPoint (WLP) to Buy, Sees 21% Upside
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
